Barr Pharmaceuticals was a global specialty and generic drug manufacturer with operations in 30 countries. On December 23, 2008, the company was acquired by Teva Pharmaceutical Industries and became part of Teva Active Pharmaceutical Ingredients (TAPI). Approximately 75% of the company's revenues were from ...
At Teva Pharmaceutical Industries, we improve people's health through our products, integrated R&D, generic medicines and global businesses.
Barr Laboratories, Inc. Barr Laboratories, Inc. is now part of Teva Pharmaceutical Industries Ltd. (July 2008). See: Teva Pharmaceuticals USA, Inc. Drugs.com Mobile Apps. The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Available for Android and ...
Company profile & key executives for Barr Laboratories Inc (0293099D:-) including description, corporate address, management team and contact info.
Barr Laboratories, Inc. is a specialty pharmaceutical company engaged in developing, manufacturing and marketing generic and proprietary pharmaceuticals. A research-intensive pharmaceutical company, Barr is listed on the New York Stock Exchange (NYSE-BRL). With fiscal 2003 revenues of $903 million, the Company ...
Aurobindo remains embroiled in litigation with Amgen on a Sensipar formulation patent, while Cipla settled ahead of bench trial. Generic firms won approval of cinacalcet generics after two federal courts denied Amgen's emergency request for an injunction in dispute with FDA over pediatric exclusivity. Generic Drugs ...
Jan 26, 2017 ... Teva Pharmaceutical Industries Ltd's Barr Laboratories Inc has reached a $225 million settlement in an antitrust class action that accused the drugmaker of keeping a generic version of Bayer AG's antibiotic Cipro off the market, court documents showed.
BRL (Common Stock). Price, 66, Change, - 1.19. Volume, 27,546,400, % Change , 1.78%. Intraday High, 67.70, 52 Week High, 68.35. Intraday Low, 65.67, 52 Week Low, 37.40. Today's Open, 66.90, Currency, US Dollar. Previous Close, 66.99, Exchange, NONE. Rolling EPS, 1.40, PE Ratio, 47. Market Cap, 7,201,546,800 ...
United States v. Barr Laboratories, Inc., 812 F. Supp. 458 (D.N.J. 1993) case opinion from the U.S. District Court for the District of New Jersey.